Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: Metabolism, diet and disease

Open Access Open Badges Poster presentation

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

Sung-Jun Park1, Faiyaz Ahmad2, Andrew Philp4, Keith Baar4, Tishan Williams5, Haibin Luo6, Hengming Ke5, Holger Rehmann7, Ronald Taussig8, Alexandra L Brown1, Myung K Kim1, Michael A Beaven3, Alex B Burgin9, Vincent Manganiello2 and Jay H Chung1*

  • * Corresponding author: Jay H Chung

Author Affiliations

1 Laboratory of Obesity and Aging Research, Genetics and Developmental Biology Center, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA

2 Cardiovascular Pulmonary Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA

3 Laboratory of Molecular Immunology, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA

4 Functional Molecular Biology Laboratory, University of California Davis, Davis, CA 95616, USA

5 Department of Biochemistry and Biophysics, The University of North Carolina, Chapel Hill, NC 27599-7260, USA

6 Structural Biology Lab, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, P. R. China

7 Department of Molecular Cancer Research, Centre for Biomedical Genetics and Cancer Genomics Centre, University Medical Center, 3584 CG Utrecht, The Netherlands

8 Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA

9 Emerald BioStructures, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA

For all author emails, please log on.

BMC Proceedings 2012, 6(Suppl 3):P73  doi:10.1186/1753-6561-6-S3-P73

The electronic version of this article is the complete one and can be found online at:

Published:27 June 2012

© 2012 Park et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Poster presentation

Resveratrol, a polyphenol in red wine, has been reported as a calorie restriction mimetic with potential antiaging and antidiabetogenic properties. It is widely consumed as a nutritional supplement, but its mechanism of action remains a mystery. Here, we report that the metabolic effects of resveratrol result from competitive inhibition of cAMP-degrading phosphodiesterases, leading to elevated cAMP levels. The resulting activation of Epac1, a cAMP effector protein, increases intracellular Ca2+ levels and activates the CamKKβ-AMPK pathway via phospholipase C and the ryanodine receptor Ca2+-release channel. As a consequence, resveratrol increases NAD+ and the activity of Sirt1. Inhibiting PDE4 with rolipram reproduces all of the metabolic benefits of resveratrol, including prevention of diet-induced obesity and an increase in mitochondrial function, physical stamina, and glucose tolerance in mice.